MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Breast Cancer Research
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

373 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
373 works in the cohort · of 4,299,418page 6 of 8

Labels cover 0 of 373 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 373 of 373 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
Peter Schmid, Javier Cortés, Ana Joaquim, Noelia Martínez-Jáñez, Serafín Morales, Tamara Díaz-Redondo +10 more
2023· article· en· Breast Cancer Research· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
17
citations
fundno affunlabeled
ERα-36 regulates progesterone receptor activity in breast cancer
Henri-Philippe Konan, Loay Kassem, Soleilmane Omarjee, Ausra Surmieliova-Garnès, Julien Jacquemetton, Elodie Cascales +5 more
2020· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
17
citations
afffundunlabeled
p66ShcA functions as a contextual promoter of breast cancer metastasis
Kyle Lewis, Alexander Kiepas, Jesse Hudson, Julien Senécal, Jacqueline R. Ha, Elena Voorand +14 more
2020· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · insufficient_payloadconsensus · none
13
citations
affunlabeled
BCoR-L1 variation and breast cancer
Felicity Lose, Jeremy M. Arnold, David B. Young, Carolyn J. Brown, Graham J. Mann, Gulietta M. Pupo +3 more
2007· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
9
citations
affunlabeled
Radiation impact in breast cancer
Joseph Ragaz
2009· review· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
9
citations
← previousnext →

How this was built: Screen · Findings · About